The journey from identifying a therapeutic target to developing a drug is fraught with challenges. One major issue is ensuring the selectivity and safety of the therapeutic agent. Drugs must be able to effectively target the toxin's mechanism without causing undue harm to the organism. Additionally, the pharmacokinetics and pharmacodynamics of the drug must be optimized to ensure it reaches the necessary tissues at therapeutic concentrations and remains effective for the required duration.
